NCT06556667View on ClinicalTrials.gov

MAX - SHOCK Clinical Trial

NARecruitingINTERVENTIONAL
Enrollment

379

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
CardioversionAtrial Fibrillation
Interventions
DEVICE

biphasic defibrillator with maximum energy of 200J (® Zoll)

Cardioversion

DEVICE

biphasic defibrillator with maximum energy of 360J (® Physio-Control)

Cardioversion

Trial Locations (1)

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

All Listed Sponsors
lead

Ottawa Heart Institute Research Corporation

OTHER